NR1I2 and obesity due to melanocortin 4 receptor deficiency: Interestingly, it has been demonstrated that PXR plays crucial roles in glucose, lipid, and bile acid metabolism, making it a potential therapeutic target in obesity and type 2 diabetes20,21.